Intelerad CEO Jordan Bazinsky outlines how advanced technology and strategic partnerships can help medical imaging withstand financial, regulatory, and workforce pressures.
Key Details
- 1Medicare radiology reimbursement declined 3.4% in 2024 and 2.83% in 2025, part of a 25% decrease since 2005.
- 2FDA staff reductions may delay imaging device and AI tool approvals, affecting innovation availability.
- 3Radiologist workforce shortage persists; ARRT exam takers fell 18% between 2006 and 2022, with demand for CT and MRI rising 3-5% yearly.
- 4AI, integrated platforms, telehealth, and compliance tools are recommended to improve efficiency, care coordination, and regulatory adherence.
- 5Collaborations with vendors and academic institutions can mitigate outsourcing and strengthen the radiologist pipeline.
Why It Matters

Source
AuntMinnie
Related News

Patients Favor AI in Imaging Diagnostics, Hesitate on Triage Use
Survey finds most patients support AI in diagnostic imaging but are reluctant about its use in triage decisions.

FDA Eases Path for AI in Clinical Decision Support and Healthcare Innovation
FDA publishes new guidance to promote innovation in general wellness and clinical decision support, impacting medical AI including radiology.

Deep Learning AI Outperforms Radiologists in Detecting ENE on CT
A deep learning tool, DeepENE, exceeded radiologist performance in identifying lymph node extranodal extension in head and neck cancers using preoperative CT scans.